Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 222 clinical trials
Featured trial
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

This study will evaluate the safety, tolerability, and potential effects on cognition of GRF6021, a plasma-derived product, administered as an intravenous (IV) infusion, to subjects with

cognitive impairment
movement disorder
dementia
  • 146 views
  • 24 Jan, 2020
  • 1 location
Featured trial
Lilly H0P-MC-CPMP – BACK PAIN

medication and one out of every three will be receive a placebo. The medication is given by an intravenous (IV) infusion every 2 weeks for a total of 4 infusions. Participants must be willing to stop taking

  • 416 views
  • 12 Oct, 2021
  • 1 location
Featured trial
Do You Experience Painful Diabetic Neuropathy?

We are currently seeking volunteers who are diagnosed with Diabetic Peripheral Neuropathic Pain and who experience pain daily.  This is a study of a new investigational medication that may help to relieve the pain of Diabetic Neuropathy.

diabetic peripheral neuropathic pain
peripheral neuropathic pain
  • 145 views
  • 12 Oct, 2021
  • 1 location
Featured trial
A Phase 4 Open-Label Study to Evaluate Vedolizumab IV Dose Optimization on Treatment Outcomes In Nonresponders With Moderately to Severely Active Ulcerative Colitis (ENTERPRET)

A Phase 4 Open-Label Study to Evaluate Vedolizumab IV Dose Optimization on Treatment Outcomes In Nonresponders With Moderately to Severely Active Ulcerative Colitis (ENTERPRET)

  • 84 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Investigational Product in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Investigational Product in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy

  • 789 views
  • 08 Nov, 2020
  • 1 location
A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke (EAISE)

> Participants will be randomized to elezanumab or placebo by intravenous (IV) infusion within 23 hours of "last known normal" (time when the participant was last known to be without signs and symptoms of the

  • 28 views
  • 25 Apr, 2022
  • 27 locations
Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

The primary objective of this study is to evaluate the safety, tolerability, and maximum tolerated dose (MTD)/maximum tolerated combination dose (MTCD) or recommended phase 2 dose (RP2D) of AMG 994 as monotherapy and AMG 994 in combination with AMG 404 in participants with advanced solid tumors.

  • 0 views
  • 19 Apr, 2022
  • 16 locations
Effects of ivAED Device on "Air-in-line" Alarms and Workflow Disruption

The investigators propose to test the hypothesis, that is, the effectiveness of the ivAED to eliminate air-in-line, comparing two commercially available, standard IV infusion pumps: the Braun

  • 0 views
  • 27 May, 2021
  • 1 location
Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients

with COVID-19 after single ascending IV infusion doses and multiple ascending IV infusion doses.

Accepts healthy volunteers
  • 3 views
  • 24 Mar, 2022
  • 2 locations
A Study of STP707 Administered by IV in Healthy Subjects

Single center study, randomized, to evaluate safety, tolerability, PK of single ascending dose of STP707 when administered by IV infusion in healthy subjects.

Accepts healthy volunteers
  • 0 views
  • 25 Apr, 2022
  • 1 location